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With the aging of the baby-boom generation and increases in life expectancy, the American population is growing older. Aging is
associated with adverse changes in glucose tolerance and increased risk of diabetes; the increasing prevalence of diabetes among
older adults suggests a clear need for eﬀective diabetes prevention approaches for this population. The purpose of paper is to
review what is known about changes in glucose tolerance with advancing age and the potential utility of resistance training
(RT) as an intervention to prevent diabetes among middle-aged and older adults. Age-related factors contributing to glucose
intolerance, which may be improved with RT, include improvements in insulin signaling defects, reductions in tumor necrosis
factor-α, increases in adiponectin and insulin-like growth factor-1 concentrations, and reductions in total and abdominal visceral
fat. Current RT recommendations and future areas for investigation are presented.
1.Introduction
With the aging of the baby boom population and an
increased life expectancy, individuals aged 65 years or older
are the fastest growing segment of our population [1].
Increases in the number of individuals aged 65+ years will
increase demands on health care and health care costs,
which could lead to inadequate public resources and less
care for the aged [1]. Chronic conditions such as diabetes
exert a profound economic impact on our nation; this
disease and its associated comorbidities are a major cause
of disability and death [2]. In 2007, the total estimated cost
of diabetes was $174 billion, which included $116 billion
in medical costs and $58 billion in reduced productivity
[3].
Total diabetes prevalence (undiagnosed and diagnosed)
is currently estimated to be 14% of the U.S adult pop-
ulation [4] and is highest in those aged ≥65 years [2].
Prediabetes, that is, impaired fasting glucose(IFG; 100mg/dl
(5.6mmol/l)–125mg/dl (6.9mmol/l)), or impaired glucose
tolerance (IGT; 2-h plasma glucose 140mg/dl (7.8mmol/l)–
199mg/dl (11.0mmol/l)) [5] is also becoming more preva-
lent in the United States [6]. Individuals with prediabetes
are at increased risk for developing diabetes, with the
progression of diabetes within 6 years of those with IFG
and IGT being 65%, as compared to a 5% progression
rate for those with normal blood glucose levels [7]. Recent
estimates indicate that by the year 2050, diabetes prevalence
could be as high as 33% [4]. The increased prevalence of
diabetes among older adults, coupled with the aging of
our population, suggests a clear need for eﬀective diabetes
prevention strategies. The purpose of the present paper is
to review what is currently known about changes in glucose
tolerance with advancing age, and the potential utility
of resistance training (RT) as an intervention to prevent
diabetes among middle-aged and older adults. Current RT
recommendations and areas for future investigation are also
presented.
2.Aging: ChangesinBodyCompositionand
GlucoseTolerance
2.1. Aging and Sarcopenia. Aging brings about a decline in
skeletal muscle mass termed sarcopenia [8–10]. Muscle mass
declines at a rate of 3–8% each decade after the age of 30
[11].Thislossofmusclemassincreasestheriskofdeveloping2 Journal of Aging Research
glucose intolerance and diabetes due to the fact that muscle
tissue is the primary site of glucose disposal [12–14].
There are many potential causes of sarcopenia including a
reduction in muscle cell number through apoptosis, loss of
motorneurons, and a reductionin calciumpumping activity.
In addition, a decrease in the muscle twitch time and force is
experienced, which can be considered a cause or an eﬀect of
sarcopenia [9, 15–17]. Increases in inﬂammatory cytokines
and oxidative stress may also contribute to sarcopenia [18].
Other consequences of this decline in muscle mass include
reduced muscle strength, reduced resting metabolic rate,
reduced lipid oxidative capacity, and increased adiposity
(reviewed in [8]). Many clinical studies have shown that
increasing lean body mass (primarily muscle mass) parallels
the improvements in glucose tolerance seen with resistance
training among older adults [19–31]. However, others have
suggested that the prevalence of glucose intolerance in
older individuals is not a direct reﬂection of one’s lean
body mass, but a result of age-associated increases in
abdominal fat [32–34]. Although lean mass may not be
the most robust predictor of glucose tolerance, the results
of numerous clinical trials suggest that increases in lean
body mass with RT are associated with improvements in
glucose tolerance [19–31]. Therefore, increasing lean mass
regardless ofbaselinelevelsshouldimproveglucosetolerance
and insulin-resistance, which may be an important strategy
to combat the age-related increases in insulin-resistance and
glucose intolerance.
2.2. Aging and Body Fat Distribution. Along with reductions
in lean mass, older individuals often experience increases
in adipose tissue [35–37]. Aging is strongly associated
with increases in body weight and body fatness [38, 39].
Based on the 2007-2008 National Health and Nutrition
Examination Survey (NHANES), 78.4% of men and 68.6%
of woman ≥60 years were considered overweight or obese
(BMI ≥ 25kg/m2). This represents the highest prevalence
of overweight or obesity across all age groups [40]. This
could partially be due to reductions in physical activity; for
example, older adults average 37% fewer steps per day when
compared to younger adults, and perform signiﬁcantly less
moderate to vigorous physical activity [41]. Older adults
often do not achieve the recommended amount of physical
activity (i.e., ≥30 minutes of moderate physical activity on
ﬁveormoredays/week)proposedbyorganizations including
the World Health Organization, Center for Disease Control
and Prevention, Health Canada, and the Department of
Health and Ageing [41].
Body fat accumulation is associated with an increased
risk of premature mortality and morbidity [39], as well as
hyperinsulinemia and glucose intolerance [38, 42]. Older
individuals also demonstrate changes in body fat distri-
bution, with increasing levels of upper body fat [35–37].
This increase in upper body fat (speciﬁcally abdominal
visceral fat) has been linked to glucose intolerance and
diabetes [43–45], and abdominal visceral fat is an inde-
pendent predictor of glucose intolerance [34, 45]. This
adipose tissue depot is sensitive to lipolytic stimuli, and
in obese states may lead to increased circulating free fatty
acid (FFA) concentrations [46, 47]. Visceral fat lipolysis
may be responsible for 5–10% of circulating FFAs in lean
individuals, while this value may increase to 20–25% in
obese individuals [47, 48]. However, upperbody, nonvisceral
fat is the primary contributor to FFA concentrations [48].
Increased FFA concentrations have been implicated in the
developmentof insulin-resistance and metabolic inﬂexibility
[47–50].
3.Aging and GlucoseIntolerance:
PotentialContributingFactors
Although factors such as a reduction in lean body mass,
physical inactivity, obesity, and changes in fat distribution
may contribute to glucose intolerance, age appears to be
an independent determinant of impaired glucose tolerance
[42, 51, 52].
3.1. Insulin Signaling within Skeletal Muscle. Insulin’s eﬀects
on peripheral tissues (i.e., skeletal muscle, adipose tissue)
involve a complex framework of signaling pathways that
result in the translocation of GLUT4 transporters to the
cell surface, which are responsible for the transport of
glucose across the plasma membrane into the target cell
[53]. An alteration in any of the related pathways reduces
insulin’s eﬀectiveness and leads to the insulin-resistance
and glucose intolerance associated with advancing age.
The insulin signaling process is complex and not fully
understood (reviewed in [53, 54]). Both diabetes and age-
associated declines in glucose tolerance are hallmarked
by a decreased uptake of glucose by peripheral tissues,
primarily skeletal muscle. The age-associated reduction in
glucose uptake is not due to impaired insulin binding,
but instead to a defect in the postreceptor intracellular
insulin signaling pathway [53, 55–57]. This defect has
not been fully elucidated; however, a reduction in the
number of insulin-stimulated glucose transport units occurs
with aging [56]. Thus, fewer GLUT-4 transporters and/or
postreceptordefectsintheinsulinsignaling cascaderesultsin
insulin-resistance. Exercise-induced, contraction-mediated
GLUT4 translocation to the muscle membrane is indepen-
dent of insulin and occurs via an alternative mechanism
(reviewed in [58]). Importantly, older adults with dimin-
ished glucose tolerance do not demonstrate a decline in
exercise-induced contractile-mediated GLUT4 translocation
[59].
3.2. Aging and Pancreatic Beta Cell Function. Insulin secre-
tion decreases at a rate of 0.7% per year with advancing
age, and is accelerated twofold in individuals with glucose
intolerance [60]; yet it is uncertain the extent to which
reduced insulin secretion is due to β-cell dysfunction or
reduced β-cell mass [60]. Individuals with glucose intol-
erance demonstrate a 50% reduction in β-cell mass [61],
which may be attributed to increased β-cell apoptosis.
The aging of β-cells appears to decrease proliferation and
increase sensitivitytohyperglycemia-inducedapoptosis[62].Journal of Aging Research 3
Diminished β-cell function has been reported among indi-
viduals with glucose intolerance, which decreases as fasting
plasma glucose concentrations increase [63]. Therefore, a
combination of β-cell dysfunction and β-cell apoptosis may
contribute to age-related declines in glucose tolerance.
3.3. Aging and Mitochondrial Function. A reduction in
mitochondrial function may also contribute to age-related
declines in glucose uptake [64–67], possibly arising from
increases in mitochondrial DNA deletions and mutations
[67, 68]. This may lead to a 40% decrease in mitochondrial
oxidative metabolism in older adults compared to younger
individuals [66]. Speciﬁcally, cytochrome c oxidase gene
expression and enzyme activity are reduced in aged skeletal
muscle [67]. This mitochondrial dysfunction contributes to
the decline in physical ﬁtness and oxidative capacity older
adults may experience [67, 69]. Insulin resistance is related
to increased plasma FFA concentrations and enhanced FFA
inﬂux into skeletal muscle [66, 70–72]; decreased mito-
chondrial oxidative capacity may cause intramyocellular
accumulation of fatty acid metabolites such as fatty acyl
coenzyme-A,diacylglycerol,andceramidetoaccumulateand
produce insulin-resistance through serine kinase activation
[65, 66, 72]. Serine kinases impede insulin signaling by
reducing IRS phosphorylation [64, 65, 72]w h i c hl e a d st o
a decline in insulin-stimulated GLUT4 translocation and
impaired skeletal muscle glucose uptake [64, 65].
3.4. Aging: Adiponectin, Tumor Necrosis Factor Alpha, and
Insulin-Like Growth Factor-1. Two strong correlates of
aging and insulin-resistance include adiponectin and tumor
necrosis factor alpha (TNF-α), with low concentrations of
adiponectin and high concentrations of TNF-α being linked
to insulin-resistance [43, 73–75]. Both may also play a role in
body fat distribution [37, 43, 44, 76, 77]a n ds a r c o p e n i a[ 18].
Adiponectin is secreted by adipose tissue (i.e., an adipokine)
and is a key modulator of insulin sensitivity [43, 75, 78]).
Low plasma adiponectin concentrations are associated with
insulin-resistance, diabetes, obesity, body fat percentage,
body fat distribution, and BMI [37, 43, 76, 79–82]. Adi-
ponectin is believed to activate 5 -AMP-activated protein
kinase(AMPK),which activatesinsulin-independentglucose
uptakebythemuscle,downregulatesgluconeogenicenzymes
and increases muscle fatty acid oxidation [83].
T u m o rn e c r o s i sf a c t o ra l p h a(T N F - α) is an inﬂammatory
cytokine secreted by adipose tissue, macrophages, and other
cells, which appears to inﬂuence insulin-resistance. Elevated
TNF-α concentrations are linked to obesity and insulin-
resistance, while obese mice lacking TNF-α are protected
from insulin-resistance [84]. Inﬂammatory pathways that
impair insulin signaling at the level of IRS proteins are acti-
vated in the presence of TNF-α [73, 84]. TNF-α is correlated
with body fat distribution [77]a n ds a r c o p e n i a[ 18]w h i c h
may also lead to insulin-resistance among individuals with
elevated TNF-α concentrations.
Unlike adiponectin and TNF-α, insulin-like growth
factor-I (ILGF-I)isnot secretedbyadiposetissue,butinstead
a peptide hormone which possesses insulin-like properties
suchasthepromotionofglucoseuptakebyperipheraltissues
[85, 86]. Insulin-like growth factor-I concentrations decline
with age, and is associated with the age-related changes in
bodycompositionbybothincreasingfatmass anddecreasing
muscle mass [87–89], thus potentially being a modulator
of insulin-resistance. Administration of recombinant ILGF-I
improves glucose uptake in those with insulin-resistance and
type 2 diabetes. Other factors may be involved in the role of
ILGF-I and glucose metabolism including binding proteins,
hybrid receptors, and growth hormone secretion [90].
4.ResistanceTraining:Inﬂuence on
Insulin Resistance
The diabetes prevention program (DPP) demonstrated that
lifestyle modiﬁcation reduces the development of diabetes
by focusing on weight loss, increased physical activity,
and dietary modiﬁcation. Lifestyle modiﬁcation decreased
the incidence of type 2 diabetes by 58%, as compared
to the 31% among individuals taking metformin [91].
The physical activity component of the DPP recom-
mended that individuals accumulate 150 minutes/week
of moderate physical activity. The DPP stressed brisk
walking as the physical activity of choice, but also lists
aerobic dance, skating, bicycle riding, and swimming as
options [91]. In support of the DPP’s recommendations
for aerobic training (AT), regular AT improves glucose
control and insulin sensitivity [92, 93]. The American
Diabetes Association (ADA) recommends that individuals
with diabetes perform at least 150 minutes of moderate-
intensity AT per week [94]. However, factors such as
obesity, arthritis, low back pain, and physical disabilities
aﬀecting many older adults may preclude this population
from regularly performing AT [95–97]. Environmental fac-
tors such as unsafe neighborhoods or streets also may
discourage engagement in many types of aerobic activ-
ity [97]. Therefore, alternative approaches for increasing
physical activity among older adults should be consid-
ered.
Resistance training is one such alternative that can be
safe and eﬀective for older adults, including the elderly
[95, 98–102]. The ADA encourages individuals with type 2
diabetes to perform resistance exercise three times a week
targeting all major muscle groups, progressing to three sets
of8–10repetitionsathighintensity[103].Byusingmachines
that provide external resistance with controlled movements,
eventhose conﬁned to a wheel chair or a walkercan perform
some types of RT. Though older adults demonstrate reduced
overall muscle protein synthesis (MPS) relative to younger
adults after a bout of resistance training [104], clinical
trials investigating RT interventions among older adults have
shown improvements in insulin-resistance and sarcopenia,
by increasing lean body mass [19–31].
Toidentifypublishedresearch relevanttothefocusofthis
paper, a literature search was conducted using the PubMed
search engine, developed by the US National Library of
Medicine of the National Institutes of Health, without
restrictions on publicationdate. Additionalinclusioncriteria4 Journal of Aging Research
were as follows: randomized controlled trial study design,
studies conducted in middle-aged and older adults, study
durationgreaterthanonemonth.Interventionstudieswhich
met inclusion criteria are described in Table 1.O ft h eR T
intervention studies reviewed, most reported improvements
in glucose uptake, and reduced diabetes risk (i.e., 4 of 5
interventions report beneﬁcial eﬀects of RT on diabetes-
related outcomes). Intensity appears to inﬂuence the mag-
nitude of improvement in these outcomes; high intensity
RT (deﬁned as training loads above 75% one-repetition
maximum(RM)[105])producesgreaterimprovementsthan
RT performed at a moderate or low intensity (training loads
between 50%–74% of one RM and below 50% one RM,
respectively [105]) [102, 106]. Although AT has been an
accepted (see DPP [91]) and recommended (ADA [94, 103])
exercise intervention to improve glucose metabolism, some
investigations of thecombinedeﬀectsofRTand ATconclude
that RT + AT exercise programs enhance diabetes related
outcomes [23, 30], while others have suggested that RT-
aloneprograms havebeneﬁtscomparabletothat ofAT-alone
programs [22, 107–109]. Evidence to support one mode of
training (RT versus AT) over the other is limited and should
be further investigated before conclusions can be made as to
the superiority of one form of exercise over the other.
Two RT modes were used in the ﬁve investigations
included in Table 1. Four interventions utilized weight-
training machines [27, 31, 79, 109] while one used ther-
abands [110]. Interestingly, all four studies using a
weight-training machine protocol reported improvements
in diabetes-related measures, whereas the RT intervention
utilizing therabands did not lead to diﬀerences between
exercise and control groups. The number of studies in this
area is limited, yet these ﬁndings suggest that RT mode
may be an important issue with regard to improvements in
glucose metabolism.
Although Table 1 only includes studies investigating
chronic RT eﬀects, others have investigated glucose me-
tabolism with acute bouts of RT, and reported conﬂicting
results. Black et al. found that a single RT session performed
at either low or high intensity, using either a multiple
set or single set protocol, improved 24-hour postexercise
insulin sensitivity measured via fasting plasma glucose[106].
Conversely, Jimenez et al. assessed insulin sensitivity using
the euglycemic-hyperinsulinemic-clamp technique preex-
ercise, and 12 and 36 hours postexercise, and reported
no diﬀerences between control and exercise groups [111].
Methodological diﬀerence may have contributed to the
conﬂicting ﬁndings (i.e., RT protocol, outcome measures,
study population). Thus it remains uncertain the extent to
which improvements in glucose/insulin metabolism with RT
could be attributed to an acute exercise bout versus a result
of chronic training.
4.1. Resistance Training: Changes in Insulin Signaling,
Adiponectin, TNF-α,a n dI L G F - 1 . Resistance-trained muscle
has shown increased rates of insulin-stimulated glucose
uptake and transport [112, 113]. This has been attributed
to the fact that RT increases aspects of the insulin signaling
cascade that result in the upregulation of this pathway.
Increases in the protein content of the insulin receptor
and kinase activity (PIP-3, Akt/PKB, aPKC) are evident in
resistance-trained muscle, even without increases in lean
mass, and may enhance glucose uptake [96, 112–114].
Akt/PKB, insulin receptor protein, and glycogen synthase
activity are increased with RT, all of which are downstream
targetsintheinsulin signalingcascadethatmaybeimportant
in the translocation of GLUT-4 receptors and skeletal
muscle glucose uptake [96]. These changes in the insulin
signaling cascade are observed even without increases in
lean mass [96]. In addition to (or possibly as a result of)
the increased activity of the insulin signaling cascade, an
increase in GLUT-4 protein concentration has also been
observed with RT in humans [96] and rodents [112–114].
Thus, the two possible insulin signaling defects that
result in insulin-resistance (decreased number of GLUT-
4 transporters and/or post receptor default in the insulin
signaling cascade resulting in less GLUT-4 translocation)
appear to be improved with RT. Increased insulin sig-
naling activity, along with increases in GLUT-4 protein
expression, may lead to increased GLUT-4 translocation
thereby increasing glucose transport and reducing insulin-
resistance.
Improvements in adiponectin concentrations have been
reported with weight loss [115–117], aerobic exercise [78,
80–82, 118]a n dR T[ 119, 120]. Since low adiponectin con-
centrations are associated with obesity, interventions often
include weight loss to promote increases in adiponectin.
However, some exercise interventions report increases in
serum adiponectin concentrations without changes in body
weight [20], although others do not [121]. There is also
conﬂicting data on the inﬂuence of RT on adiponectin
concentrations; some have reported no change [79,116, 122]
while others have reported increases [119, 120]. Method-
ological diﬀerences (i.e., RT intensity, measurement of total
versus low/high molecular weight adiponectin) may explain
conﬂictingﬁndings. With regard toTNF-α,highintensityR T
appearstoreduceTNF-αconcentrationsandimproveinsulin
sensitivity [20, 123, 124], even when fat mass is unchanged
[20].
There is conﬂicting data on the inﬂuence of RT on
ILGF-I concentrations. Borst et al. reported that 25 weeks
of 1 or 3-set resistance training increased ILGF-I in healthy
adults aged 25 to 50 [125]; however, this was not observed
in a subsequent study by the same group using adults
aged 60–85 years and high and low-intensity resistance
training [126]. Conversely, others have reported signiﬁcant
increases in ILGF-I with resistance training in the elderly
[99, 127]. These studies concluded that despite atrophy and
ultrastructural damage, eldersrespond to RTwith signiﬁcant
increases inmusculoskeletalremodeling, cross-sectional area
and elevated IGF-I levels [99, 127]. Increases in ILGF-I
concentration are also associated with increases in lean mass,
indicating that ILGF-I may be important in addressing age-
related sarcopenia and insulin-resistance. Although more
research is needed in this area, it appears that ILGF-I
concentrations can be increased in older adults to augment
glucose uptake and improve insulin-resistance.Journal of Aging Research 5
Table 1: Randomized controlled trials >1 month in duration investigating the eﬀect of resistance training on diabetes-related outcomes
amongnondiabetic middle-aged and older adults†.
Source Study design Study
duration RT protocol Study population Primary ﬁndings
Traditional Weight Training only∗
Iglay et al. [27]
RCT (n = 36):
RT + 0.9/g/kg/d
protein intake,
n = 16
RT + 1.2 g/kg/d,
n = 16
3m o n t h s
3x week, 8 machine
exercises, 2 sets 8 reps +
one set to voluntary fatigue
at high intensity
Healthy individuals,
aged 60–62yrs.
↓ glucose OGTT AUC 25–28%
with RT, no diﬀerences between
diet groups.
Onamb´ el´ e-
Pearson et al.
[110]
RCT (n = 30):
LI (∼40% 1RM),
n = 18
HI (∼80% 1RM),
n = 12
3m o n t h s
3x week, 6 exercises using
therabands, progressing
from 8–11 reps and 2–4
sets, diﬀerent intensity
groups: HI versus LI
Sedentary individuals,
aged 55–80yrs.
↑ fasting plasma glucose (4.8 ±
0.19 to 5.51 ± 0.08mmol/L) in
HI group, no change in plasma
glucose for LI, no change in
plasma insulin for either group.
Zachwieja et al.
[31]
RCT (n = 15):
RT + GH
injections,
n = 6
RT only, n = 9
4m o n t h s
4x week, 9 machine
exercises, 4 sets, 4–10 reps
at high intensity.
Healthy men, aged
64–75yrs.
↑ in glucose disappearance rate
(3.0 ± 0.3 to 4.0 ±
0.4mg/100mL/min minimal
model of glucose kinetics,
IVGTT) with RT only
RT + AT (either alone or combined)
Ahmadizad et al.
[79]
RCT (n = 24):
AT, n = 8
RT, n = 8
Control, n = 8
3m o n t h s
3x week, circuit weight
training, 11 machine
exercises, 4 sets, 12 reps, at
moderate intensity with
30sec. rest between
exercises.
Healthy men, aged
35–48yrs.
↓ HOMA-IR 35.7 and 38.5%
after AT and RT respectfully; no
diﬀerences between groups.
Smutok et al.
[109]
RCT (n = 37):
RT, n = 14
AT, n = 13
Control, n = 10
4.5
months
3x week, 11 machine
exercises, 2 sets, 12–15 reps
at moderate intensity.
Men at risk for CHD
with either abnormal
glucose tolerance,
dyslipidemia, or
hypertension, aged
41–59yrs.
↓ plasma glucose at 60, 90, and
120 minutes after glucose
ingestion with RT; ↓ plasma
glucose at 90 and 120min after
glucose ingestion with AT. ↓
fasting glucose with RT, no
changes with AT. Insulin OGTT
AUC ↓ 24% for AT and 21% for
RT, no changes in control.
∗Traditional Weight Training= any muscle strengthening exercises using resistance training machines/equipment, free weights (e.g., dumbbell, barbell) or
therabands.
†Abbreviations used: AT: Aerobic training, AUC: Area under curve, GH: Growth Hormone, HI: High intensity, HOMA: Homeostasis model assessment,
IVGTT: Intravenous glucose tolerance test, IR: Insulin Resistance, LI: Low intensity, OGTT: Oral glucose tolerance test, Reps: Repetitions, RCT: Randomized
controlled trial, RT: Resistance training.
4.2. Resistance Training and Body Fat Distribution. Body fat
distribution may play a major role in the development of
insulin-resistance, particularly abdominal fat [33, 42]. Resis-
tance training reduces abdominal fat, including visceral fat,
among individuals with diabetes [116, 128, 129]. Both low
intensity RT three times per week [128], and high intensity
RT twice per week [116] improve insulin-resistance and
reduce body fat mass. Strength training-induced changes in
abdominal visceral fat were also reported without signiﬁcant
weightloss[129].Thus,RTalonemayreduceabdominaland
visceral fat, which is known to increase with advancing age
and inﬂuence insulin-resistance.
An overview of how RT may inﬂuence age-related
physiological changes impacting diabetes risk is presented
graphically in Figure 1.
5.CurrentRecommendations:Aging,
ResistanceTraining,and Diabetes Prevention
Major health organizations such as the American College
of Sports Medicine (ACSM), American Heart Association
(AHA), and the American Geriatrics Society (AGS) have
issued recommendations regarding RT for older or dia-
betic individuals. As stated previously, the ADA encourages
individuals with type 2 diabetes to perform resistance
exercise three times per week targeting all major muscle
groups, and progressing to three sets of 8–10 repetitions
at high intensity [103]. According to the ACSM, older
adults should engage in RT at least twice per week. These
sessions should include 8–10 exercises of 8–12 repetitions,
involving the major muscle groups, done at a moderate6 Journal of Aging Research
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Figure 1: Age-related physiological changes and diabetes risk: Potential inﬂuence of RT.
to vigorous intensity [130]. Similarly, ACSM’s position
stand on exercise prescription for diabetes care recommends
that individuals engage in RT at least twice per week,
with 8–10 exercise involving the major muscle groups to
be performed with at least one set of 10–15 repetitions.
This position stand recognizes that increased intensity of
exercise or adding additional sets may produce greater
beneﬁts, but may not be appropriate for some individuals
[131]. Both ACSM position stands advocate progressive RT,
with increases in resistance as the individual progresses
through the program [130, 131]. The AGS recommends
2-3 days per week of RT with 10–15 repetitions at low
intensity, 8–10 at moderate intensity, or 6–8 at high intensity
[132]. The AHA recommends that older adults engage in
resistance training 2-3 nonconsecutive days per week doing
one set of 10–15 repetitions at low intensity, and also
recognizes that multiple set regimens performed at higher
intensities and frequencies (>2 days a week) may provide
greater beneﬁts [133]. These recommendations are similar
to protocols used in many clinical trials investigating the
eﬀectofRTondiabetes-relatedoutcomesamongolderadults
(see Table 1). Two of the four trials included in Table 1
used a high intensity protocol, while 2 used moderate
intensities and one had high intensity and low intensity
groups. All of the studies used multiple set protocols.
Frequency of training was most commonly three days per
week (n = 4), while one study used a 4 day per week
protocol.
Some studies have addressed the issue of RT intensity
and volume on insulin sensitivity. High-intensity protocols
show signiﬁcant increases in insulin sensitivity as compared
with moderate intensity protocols [106], and single set
protocols may be less eﬀective than multiple set protocols
in lowering fasting blood glucose concentrations [106]. A
meta analysis concluded that high intensity protocols were
more eﬀective than low intensity protocols at increasing
strength in older adults [102]. Higher volume interventions
are also associated with greater increases in lean body mass
in older individuals [134]a sw e l la sy o u n gm e n[ 135]. This
suggests the possibility of a dose-response relationship, such
that improvements in strength and insulin-resistance are
increased as RT intensity and volume increase. Additionally,
others have reported that twice weekly RT at low intensity
but high volume (three sets of ten repetitions) improved
insulin-resistance [136]. Recently, RT interventions stressing
volitional fatigue (i.e., the point at which the exercise
could not be completed with proper technique) have been
conducted [137, 138]; more work is needed to determine if
this RT approach is beneﬁcial with respect to blood glucose
control and insulin-resistance.
Taken together, existing recommendations and these
research studies suggest that high volume and high intensity
RT may produce greater improvements in muscle mass
gains, insulin-resistance and glucose tolerance; however, it
would be prudent for sedentary older diabetic or prediabetic
individuals to begin an RT program at low intensity (rate
of perceived exertion of ∼5-6) and low volume (1 set per
exercise, 10–12 reps) twice weekly, and if time and ﬁtness
are suﬃcient, progressively increasing intensity, volume, and
frequency [130, 131, 133].Journal of Aging Research 7
5.1. Future Directions. Research suggests that RT may play
a role in improving the age-related increases in insulin-
resistance, and prevent the onset of diabetes. Major health
organizations have recognized the beneﬁts of RT. However,
according to the CDC, only 13% of men and less than
10% of woman aged ≥65yrs reported engaging in strength
training at least two daysper week [139]. Possible reasons for
low rates of adoption and minimal adherence may include
barriers such as the perceived complexity and knowledge
needed to perform RT, misinformation of expected RT
outcomes (e.g., excessive or undesirable hypertrophy), and
the emphasis many public health programs and clinicians
place on AT rather than RT. Once eﬀective RT interventions
are identiﬁed, the translational capabilities of intervention
approaches should be investigated. Adherence, simplicity,
and cost eﬀectiveness are important for RT interventions to
be successful in real-world settings.
Diﬀerences in traditional RT versus circuit weight train-
ing have not been addressed, as well as diﬀerences in proto-
cols using free weights and those using machine weights. It
is possible that certain RT approaches lead to greater rates
of adoption, adherence and greater cost eﬀectiveness among
older, insulin resistant individuals.
Dietary and weight loss interventions in conjunction
with RT should be investigated to determine the optimal
approach for diabetes prevention with advancing age. For
example,the roledietary proteinintakemayplayin reversing
insulin-resistance and improving glucose control should be
studied more in depth, as high protein diets improve glucose
control in individuals with type 2 diabetes when compared
to those on a low protein diet [140, 141]. Additionally, a
positive relationship between protein intake and change in
whole body fat-free mass has been observed after pooling
RT studies investigating protein intake in adults aged 50–80
[142]. Based upon these ﬁndings, it has been suggested that
the RDA for protein intake (0.8g/kg) is inadequate for older
adultswho engage in RT[142].With the possibility that high
protein diets can be beneﬁcial to those with impairments in
glucose metabolism as well as older adults engaging in RT,
the synergistic eﬀect of RT and high protein diets on glucose
tolerance warrants further investigation.
Finally, additionalwork should bedonetoaddressmech-
anisms for RT-induced improvements in insulin-resistance
and glucose tolerance. The speciﬁc eﬀects of RT on insulin
signaling are uncertain, and the eﬀect of RT on pancre-
atic β-cell function/mass and mitochondrial dysfunction
are unknown. It is also possible that other inﬂammatory
markers not yet identiﬁed may inﬂuence sarcopenia and
the response to RT among older adults. Although some
work has been done addressing the eﬀect of RT on visceral
adipose tissue [76, 77], direct eﬀects on FFA concentrations
and gluconeogenesis are uncertain. By continuing to identify
the mechanisms by which RT improves insulin-resistance,
and by determining optimal combinations of RT with other
lifestyle factors to prevent diabetes, interventions can be
developed which optimize reduction in diabetes risk with
advancing age.
In conclusion,itappearsRTmaybean eﬀectiveinterven-
tionapproachformiddle-agedandolderadultstocounteract
age-associated declines in insulin sensitivity and to prevent
the onset of type 2 diabetes. Older adults who engage in
RT may see beneﬁts with respect to improvements in body
composition, body fat distribution, inﬂammatory markers,
and blood glucose homeostasis. Future research investigat-
ing mechanisms, optimal RT protocol, and intervention
approaches with high translation potential are needed to
enhance knowledge in this area, and to increase public
awareness and adoption of RT.
Acknowledgments
This work was supported in part by K01KD075424 (to
BrendaM.Davy)andR01DK082383(toBrendaM.Davyand
Richard A. Winett).
References
[1] Centers for Disease Control and Prevention, “Public health
and aging: trends in aging—United States and worldwide,”
The Journal of the American Medical Association, vol. 289, no.
11, pp. 1371–1373, 2003.
[ 2 ]A .M .M c B e a n ,S .L i ,D .T .G i l b e r t s o n ,a n dA .J .C o l l i n s ,
“Diﬀerences in diabetes prevalence, incidence, and mortality
amongtheelderlyoffourracial/ethnicgroups:whites,blacks,
Hispanics, and Asians,” Diabetes Care, vol. 27, no. 10, pp.
2317–2324, 2004.
[3] T. Dall, S. E. Mann, Y. Zhang et al., “Economic costs of
diabetes in the U.S. in 2007,” Diabetes Care, vol. 31, no. 3,
pp. 596–615, 2008.
[4] J. P. Boyle et al., “Projection of the year 2050 burden of
diabetes in the US adult population: dynamic modeling of
incidence, mortality, and prediabetes prevalence,” Population
Health Metrics, vol. 8, no. 1, p. 29, 2010.
[5] “Standardsofmedicalcareindiabetes—2009,”DiabetesCare,
vol. 32, supplement 1, pp. S13–S61, 2009.
[6] S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu,
“Screening adultsfortype 2diabetes: areview oftheevidence
for the U.S. preventive services task force,” Annals of Internal
Medicine, vol. 148, no. 11, pp. 855–868, 2008.
[7] E. L. M. Barr, P. Z. Zimmet, T. A. Welborn et al., “Risk of
cardiovascular and all-cause mortality in individuals with
diabetes mellitus, impaired fasting glucose, and impaired
glucose tolerance: the Australian Diabetes, Obesity, and
Lifestyle Study (AusDiab),” Circulation, vol. 116, no. 2, pp.
151–157, 2007.
[8] B. Strasser, U. Siebert, and W. Schobersberger, “Resistance
training in the treatment of the metabolic syndrome: a
systematicreview andmeta-analysisoftheeﬀect ofresistance
training on metabolic clustering in patients with abnormal
glucosemetabolism,”SportsMedicine,vol.40,no.5, pp. 397–
415, 2010.
[9] J. Lexell, C. C. Taylor, and M. Sjostrom, “What is the cause
of the ageing atrophy? Total number, size and proportion of
diﬀerent ﬁber types studied in whole vastus lateralis muscle
from 15- to 83-year-old men,” Journal of the Neurological
Sciences, vol. 84, no. 2-3, pp. 275–294, 1988.
[10] R. Roubenoﬀ and C. Castaneda, “Sarcopenia—understand-
ing the dynamics of aging muscle,” Journal of the American
Medical Association, vol. 286, no. 10, pp. 1230–1231, 2001.
[11] G. Percheron, J. Y. Hogrel, S. Denot-Ledunois et al., “Eﬀect
of 1-year oral administration of dehydroepiandrosterone8 Journal of Aging Research
to 60- to 80-year-old individuals on muscle function and
cross-sectionalarea:adouble-blind placebo-controlled trial,”
Archives of Internal Medicine, vol. 163, no. 6, pp. 720–727,
2003.
[12] C. Dutta and E. C. Hadley, “The signiﬁcance of sarcopenia
in old age,” Journals of Gerontology A, Biological Sciences and
Medical Sciences, vol. 50, pp. 1–4, 1995.
[13] L.J.MeltonIII,S.Khosla,C.S.Crowson,M.K.O’Connor,W.
M. O’Fallon, and B. L. Riggs, “Epidemiology of sarcopenia,”
Journal of the American Geriatrics Society,v o l .4 8 ,n o .6 ,p p .
625–630, 2000.
[14] A. A. Sayer, H. E. Syddall, E. M. Dennison et al., “Grip
strength and the metabolic syndrome: ﬁndings from the
Hertfordshire Cohort Study,” Quarterly Journal of Medicine,
vol. 100, no. 11, pp. 707–713, 2007.
[15] J. Lexell, “Human aging, muscle mass, and ﬁber type
composition,” Journals of Gerontology A, Biological Sciences
and Medical Sciences, vol. 50, pp. 11–16, 1995.
[16] A. A. Vandervoort, “Aging of the human neuromuscular
system,” Muscle and Nerve, vol. 25, no. 1, pp. 17–25, 2002.
[17] L. A. Burton and D. Sumukadas, “Optimal management of
sarcopenia,” Clinical Interventions in Aging, vol. 5, pp. 217–
228, 2010.
[18] G. L. Jensen, “Inﬂammation: roles in aging and sarcopenia,”
J o u r n a lo fP a r e n t e r a la n dE n t e r a lN u t r i t i o n ,v o l .3 2 ,n o .6 ,p p .
656–659, 2008.
[19] J. C. Baldi and N. Snowling, “Resistance training improves
glycaemiccontrolinobesetype2diabeticmen,”International
Journal of Sports Medicine, vol. 24, no. 6, pp. 419–423, 2003.
[20] S. Balducci, S. Zanuso, A. Nicolucci et al., “Anti-
inﬂammatory eﬀect of exercise training in subjects with
type 2 diabetes and the metabolic syndrome is dependent
on exercise modalities and independent of weight loss,”
Nutrition, Metabolism and Cardiovascular Diseases, vol. 20,
no. 8, pp. 608–617, 2010.
[21] C. Castaneda, J. E. Layne, L. Munoz-Orians et al., “A
randomized controlled trial of resistance exercise training
to improve glycemic control in older adults with type 2
diabetes,” DiabetesCare, vol.25,no.12,pp. 2335–2341,2002.
[22] E. Cauza,U.Hanusch-Enserer, B. Strasseret al.,“The relative
beneﬁts ofendurance and strength training on the metabolic
factors and muscle function of people with type 2 diabetes
mellitus,” Archives of Physical Medicine and Rehabilitation,
vol. 86, no. 8, pp. 1527–1533, 2005.
[23] D. J. Cuﬀ, G. S. Meneilly, A. Martin, A. Ignaszewski, H. D.
Tildesley, and J. J. Frohlich, “Eﬀective exercise modality to
reduce insulin resistance in women with type 2 diabetes,”
Diabetes Care, vol. 26, no. 11, pp. 2977–2982, 2003.
[24] D. W. Dunstan, R. M. Daly, N. Owen et al., “High-
intensity resistance training improves glycemic control in
older patients with type 2 diabetes,” Diabetes Care, vol. 25,
no. 10, pp. 1729–1736, 2002.
[25] D. W. Dunstan, E. Vulikh, N. Owen, D. Jolley, J. Shaw, and
P. Zimmet, “Community center-based resistance training for
the maintenance of glycemic control in adults with type 2
diabetes,” DiabetesCare, vol.29,no.12,pp. 2586–2591,2006.
[ 2 6 ]L .M .F e n i c c h i a ,J .A .K a n a l e y ,J .L .A z e v e d oe ta l . ,“ I n ﬂ u e n c e
of resistance exercise training on glucose control in women
withtype 2diabetes,” Metabolism,vol.53,no.3,pp. 284–289,
2004.
[27] H.B.Iglay,J.P.Thyfault,J.W.Apolzan,andW.W.Campbell,
“Resistance training and dietary protein: eﬀects on glucose
tolerance and contents of skeletal muscle insulin signaling
proteins in older persons,” American Journal of Clinical
Nutrition, vol. 85, no. 4, pp. 1005–1013, 2007.
[28] T. Ishii, T. Yamakita, T. Sato, S. Tanaka, and S. Fujii,
“Resistance training improves insulin sensitivity in NIDDM
subjects without altering maximal oxygen uptake,” Diabetes
Care, vol. 21, no. 8, pp. 1353–1355, 1998.
[29] A. Maiorana, G. O’Driscoll, C. Goodman, R. Taylor, and D.
Green, “Combined aerobic and resistance exercise improves
glycemic control and ﬁtness in type 2 diabetes,” Diabetes
Research and Clinical Practice, vol. 56, no. 2, pp. 115–123,
2002.
[30] R. J. Sigal, G. P. Kenny, N. G. Boule et al., “Eﬀects of aerobic
training, resistance training, or both on glycemic control
in type 2 diabetes: a randomized trial,” Annals of Internal
Medicine, vol. 147, no. 6, pp. 357–369, 2007.
[31] J. J. Zachwieja, G. Toﬀolo, C. Cobelli, D. M. Bier, and
K. E. Yarasheski, “Resistance exercise and growth hormone
administrationinoldermen:eﬀectsoninsulinsensitivityand
secretion during a stable-label intravenous glucose tolerance
test,” Metabolism, vol. 45, no. 2, pp. 254–260, 1996.
[ 3 2 ]J .L .K u k ,K .K i l p a t r i c k ,L .E .D a v i d s o n ,R .H u d s o n ,a n d
R. Ross, “Whole-body skeletal muscle mass is not related
to glucose tolerance or insulin sensitivity in overweight and
obese men and women,” Applied Physiology, Nutrition and
Metabolism, vol. 33, no. 4, pp. 769–774, 2008.
[ 3 3 ]W .M .K o h r t ,J .P .K i r w a n ,M .A .S t a t e n ,R .E .B o u r e y ,D .S .
King,andJ.O.Holloszy,“Insulinresistanceinagingisrelated
to abdominal obesity,” Diabetes, vol. 42, no. 2, pp. 273–281,
1993.
[ 3 4 ]C .U s u i ,M .A s a k a ,H .K a w a n oe ta l . ,“ V i s c e r a lf a ti sas t r o n g
predictor of insulin resistance regardless of cardiorespiratory
ﬁtness in non-diabetic people,” Journal of Nutritional Science
and Vitaminology, vol. 56, no. 2, pp. 109–116, 2010.
[35] T. Douchi, S. Yamamoto, N. Yoshimitsu, T. Andoh, T.
Matsuo, and Y. Nagata, “Relative contribution of aging and
menopause to changes in lean and fat mass in segmental
regions,” Maturitas, vol. 42, no. 4, pp. 301–306, 2002.
[ 3 6 ]J .L .K u k ,T .J .S a u n d e r s ,L .E .D a v i d s o n ,a n dR .R o s s ,“ A g e -
related changes in total and regional fat distribution,” Ageing
Research Reviews, vol. 8, no. 4, pp. 339–348, 2009.
[37] E. Zoico, V. Di Francesco, G. Mazzali et al., “Adipocytokines,
fat distribution, and insulin resistance in elderly men and
women,” Journals of Gerontology A, Biological Sciences and
Medical Sciences, vol. 59, no. 9, pp. M935–M939, 2004.
[38] A. S. Ryan, “Insulin resistance with aging: eﬀects of diet and
exercise,” Sports Medicine, vol. 30, no. 5, pp. 327–346, 2000.
[39] J. Stevens, J. Cai, E. R. Pamuk, D. F. Williamson, M. J. Thun,
andJ .L.W ood ,“T hee ﬀect of age on the associationbetween
body-mass index and mortality,” New England Journal of
Medicine, vol. 338, no. 1, pp. 1–7, 1998.
[40] K. M. Flegal, M. D. Carroll, C. L. Ogden, and L. R. Curtin,
“Prevalence and trends in obesity among US adults, 1999–
2008,” Journal of the American Medical Association, vol. 303,
no. 3, pp. 235–241, 2010.
[41] M. G. Davis and K. R. Fox, “Physical activity patterns
assessed by accelerometry in older people,” European Journal
of Applied Physiology, vol. 100, no. 5, pp. 581–589, 2007.
[42] P. J. Coon, E. M. Rogus, D. Drinkwater, D. C. Muller, and
A. P. Goldberg, “Role of body fat distribution in the decline
in insulin sensitivity and glucose tolerance with age,” Journal
of Clinical Endocrinology and Metabolism,v o l .7 5 ,n o .4 ,p p .
1125–1132, 1992.
[ 4 3 ] M .C n o p ,P .J .H a v e l ,K .M .U t z s c h n e i d e re ta l . ,“ R e l a t i o n s h i p
of adiponectin to body fat distribution, insulin sensitivityJournal of Aging Research 9
and plasma lipoproteins: evidence for independent roles of
age and sex,” Diabetologia, vol. 46, no. 4, pp. 459–469, 2003.
[ 4 4 ]G .M a z z a l i ,V .D iF r a n c e s c o ,E .Z o i c oe ta l . ,“ I n t e r r e l a t i o n s
between fat distribution, muscle lipid content, adipocy-
tokines,and insulinresistance: eﬀect of moderate weight loss
in older women,” American Journal of Clinical Nutrition,v o l .
84, no. 5, pp. 1193–1199, 2006.
[45] S. Sandeep, K. Gokulakrishnan, K. Velmurugan, M. Deepa,
and V. Mohan, “Visceral & subcutaneous abdominal fat in
relation to insulin resistance & metabolic syndrome in non-
diabetic south Indians,” Indian Journal of Medical Research,
vol. 131, no. 5, pp. 629–635, 2010.
[46] P.Bjorntorp,“’Portal’adiposetissueasageneratorofriskfac-
tors for cardiovascular disease and diabetes,” Arteriosclerosis,
vol. 10, no. 4, pp. 493–496, 1990.
[47] S. Nielsen, Z. Guo, C. M. Johnson, D. D. Hensrud, and M.
D. Jensen,“Splanchnic lipolysis in human obesity,” Journal of
Clinical Investigation, vol. 113, no. 11, pp. 1582–1588, 2004.
[48] M. D. Jensen, “Is visceral fat involved in the pathogenesis of
the metabolic syndrome? Human model,” Obesity, vol. 14,
supplement 1, pp. 20S–24S, 2006.
[49] J.E. Galgani,C. Moro,andE.Ravussin,“Metabolicﬂexibility
and insulin resistance,” American Journal of Physiology,v o l .
295, no. 5, pp. E1009–E1017, 2008.
[ 5 0 ]G .B o c k ,C .D .M a n ,M .C a m p i o n ie ta l . ,“ P a t h o g e n e s i s
of pre-diabetes: mechanisms of fasting and postprandial
hyperglycemia in people with impaired fasting glucose
and/or impaired glucose tolerance,” Diabetes, vol. 55, no. 12,
pp. 3536–3549, 2006.
[51] M. S. Katz and D. T. Lowenthal, “Inﬂuences of age and exer-
cise on glucose metabolism: implications for managementof
older diabetics,” Southern Medical Journal, vol. 87, no. 5, pp.
S70–S73, 1994.
[52] H. Shimokata, D. C. Muller, J. L. Fleg, J. Sorkin, A. W.
Ziemba, and R. Andres, “Age as independent determinant of
glucose tolerance,” Diabetes, vol. 40, no. 1, pp. 44–51, 1991.
[53] M. J. Brady and A. R. Saltiel, “Closing in on the cause of
insulin resistance and type 2 diabetes,” Journal of Clinical
Investigation, vol. 104, no. 6, pp. 675–676, 1999.
[54] A. Klip, “The many ways to regulate glucose transporter 4,”
Applied Physiology, Nutrition and Metabolism,v o l .3 4 ,n o .3 ,
pp. 481–487, 2009.
[55] R. A. Jackson, P. M. Blix, and J. A. Matthews, “Inﬂuence
of ageing on glucose homeostasis,” Journal of Clinical
Endocrinology and Metabolism, vol. 55, no. 5, pp. 840–848,
1982.
[ 5 6 ]R .I .F i n k ,P .W a l l a c e ,a n dJ .M .O l e f s k y ,“ E ﬀects of aging
onglucose-mediatedglucosedisposalandglucosetransport,”
Journal of Clinical Investigation,vol.77,no.6,pp. 2034–2041,
1986.
[57] R. H. Noth and E. L. Mazzaferri, “Age and the endocrine
system,” Clinics in Geriatric Medicine, vol. 1, no. 1, pp. 223–
250, 1985.
[58] J. O. Holloszy, “Invited review: exercise-induced increase in
muscle insulin sensitivity,” Journal of Applied Physiology,v o l .
99, no. 1, pp. 338–343, 2005.
[59] C. Skov-Jensen, M. Skovbro, A. Flint, J. W. Helge, and F.
Dela, “Contraction-mediated glucose uptake is increased in
men with impaired glucose tolerance,” Applied Physiology,
Nutrition and Metabolism, vol. 32, no. 1, pp. 115–124, 2007.
[60] E. Szoke, M. Z. Shrayyef, S. Messing et al., “Eﬀect of aging
on glucose homeostasis: accelerated deterioration of β-cell
function in individuals with impaired glucose tolerance,”
Diabetes Care, vol. 31, no. 3, pp. 539–543, 2008.
[ 6 1 ]A .E .B u t l e r ,J .J a n s o n ,S .B o n n e r - W e i r ,R .R i t z e l ,R .A .R i z z a ,
and P. C. Butler, “β-cell deﬁcit and increased β-cell apoptosis
in humans with type 2 diabetes,” Diabetes,v o l .5 2 ,n o .1 ,p p .
102–110, 2003.
[62] K. Maedler, D. M. Schumann, F. Schulthess et al., “Aging
correlates with decreased β-cell proliferative capacity and
enhanced sensitivity to apoptosis: a potential role for fas and
pancreatic duodenal homeobox-1,” Diabetes,v o l .5 5 ,n o .9 ,
pp. 2455–2462, 2006.
[63] T. W. Van Haeften, W. Pimenta, A. Mitrakou et al., “Relative
contributions of β-cell function and tissue insulin sensitivity
to fasting and postglucose-load glycemia,” Metabolism,v o l .
49, no. 10, pp. 1318–1325, 2000.
[64] J. A. Kim, Y. Wei, and J. R. Sowers, “Role of mitochondrial
dysfunction in insulin resistance,” Circulation Research,v o l .
102, no. 4, pp. 401–414, 2008.
[65] M. A. Abdul-Ghani and R. A. DeFronzo, “Mitochondrial
dysfunction, insulin resistance, and type 2 diabetes mellitus,”
Current Diabetes Reports, vol. 8, no. 3, pp. 173–178, 2008.
[66] K. F. Petersen, D. Befroy, S. Dufour et al., “Mitochondrial
dysfunction intheelderly: possibleroleininsulinresistance,”
Science, vol. 300, no. 5622, pp. 1140–1142, 2003.
[67] R. Barazzoni, K. R. Short, and K. S. Nair, “Eﬀects of aging
on mitochondrial DNA copy number and cytochrome c
o x i d a s eg e n ee x p r e s s i o ni nr a ts k e l e t a lm u s c l e ,l i v e r ,a n d
heart,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y , vol. 275, no. 5, pp.
3343–3347, 2000.
[ 6 8 ]G .A .C o r t o p a s s i ,D .S h i b a t a ,N .W .S o o n g ,a n dN .A r n h e i m ,
“A pattern of accumulation of a somatic deletion of mito-
chondrial DNA in aging human tissues,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 89, no. 16, pp. 7370–7374, 1992.
[69] S. Sial, A. R. Coggan, R. Carroll, J. Goodwin, and S. Klein,
“Fat and carbohydrate metabolism during exercise in elderly
andyoungsubjects,” American Journal ofPhysiology,vol.271,
no. 6, part 1, pp. E983–E989, 1996.
[70] G. Perseghin, P. Scifo, F. De Cobelli et al., “Intramyocellular
triglyceride content is a determinant of in vivo insulin
resistance in humans: a H-C nuclear magnetic resonance
spectroscopy assessment in oﬀspring of type 2 diabetic
parents,” Diabetes, vol. 48, no. 8, pp. 1600–1606, 1999.
[71] M.Krssak,K.FalkPetersen,A.Dresner etal.,“Intramyocellu-
lar lipid concentrations are correlated with insulin sensitivity
in humans: a H NMR spectroscopy study,” Diabetologia,v o l .
42, no. 1, pp. 113–116, 1999.
[72] M. E. Griﬃn ,M .J .M a r c u c c i ,G .W .C l i n ee ta l . ,“ F r e ef a t t y
acid-induced insulin resistance is associated with activation
of protein kinase C θ and alterations in the insulin signaling
cascade,” Diabetes, vol. 48, no. 6, pp. 1270–1274, 2000.
[73] I. Nieto-Vazquez, S. Fern´ andez-Veledo, D. K. Kr¨ amer, R.
Vila-Bedmar, L. Garcia-Guerra, and M. Lorenzo, “Insulin
resistanceassociatedtoobesity:thelinkTNF-alpha,”Archives
of Physiology and Biochemistry, vol. 114, no. 3, pp. 183–194,
2008.
[74] K. Rabe, M. Lehrke, K. G. Parhofer, and U. C. Broedl,
“Adipokines and insulin resistance,” Molecular Medicine,v o l .
14, no. 11-12, pp. 741–751, 2008.
[75] U. B. Pajvani and P. E. Scherer, “Adiponectin: systemic
contributor to insulin sensitivity,” Current Diabetes Reports,
vol. 3, no. 3, pp. 207–213, 2003.
[ 7 6 ]A .M .K a n a y a ,T .H a r r i s ,B .H .G o o d p a s t e r ,F .T y l a v s k y ,a n d
S. R. Cummings, “Adipocytokines attenuate the association
between visceral adiposity and diabetes in older adults,”
Diabetes Care, vol. 27, no. 6, pp. 1375–1380, 2004.10 Journal of Aging Research
[77] A. Koster, S. Stenholm, D. E. Alley et al., “Body fat
distribution and inﬂammation among obese older adults
with and without metabolic syndrome,” Obesity, vol. 18, no.
12, pp. 2354–2361, 2010.
[78] S. Lim, H. C. Sung, IN. K. Jeong et al., “Insulin-sensitizing
eﬀects of exercise on adiponectin and retinol-binding
protein-4concentrationsinyoungandmiddle-agedwomen,”
Journal of Clinical Endocrinology and Metabolism,v o l .9 3 ,n o .
6, pp. 2263–2268, 2008.
[79] S. Ahmadizad, A. H. Haghighi, and M. R. Hamedinia,
“Eﬀects of resistance versus endurance training on serum
adiponectin and insulin resistance index,” European Journal
of Endocrinology, vol. 157, no. 5, pp. 625–631, 2007.
[80] M. Bl¨ u h e r ,C .J .W i l l i a m s ,N .K l¨ oting et al., “Gene expression
ofadiponectin receptors inhumanvisceralandsubcutaneous
adipose tissue is related to insulin resistance and metabolic
parameters and is altered in response to physical training,”
Diabetes Care, vol. 30, no. 12, pp. 3110–3115, 2007.
[81] M. Bl¨ uher, J. W. Bullen, J. H. Lee et al., “Circulating
adiponectin and expression of adiponectin receptors in
human skeletal muscle: associations with metabolic param-
eters and insulin resistance and regulation by physical
training,” Journal of Clinical Endocrinology and Metabolism,
vol. 91, no. 6, pp. 2310–2316, 2006.
[82] E. S. Kim, J.-A. Im, K. C. Kim et al., “Improved insulin
sensitivity and adiponectin level after exercise training in
obese Korean youth,” Obesity, vol. 15, no. 12, pp. 3023–3030,
2007.
[83] T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin
stimulates glucose utilization and fatty-acid oxidation by
activating AMP-activated protein kinase,” Nature Medicine,
vol. 8, no. 11, pp. 1288–1295, 2002.
[84] G. S. Hotamisligil, “Inﬂammatory pathways and insulin
action,” International Journal of Obesity, vol. 27, supplement
3, pp. S53–S55, 2003.
[85] D. Le Roith, “Insulin-like growth factors,” New England
Journal of Medicine, vol. 336, no. 9, pp. 633–640, 1997.
[86] E. Rinderknecht and R. E. Humbel, “The amino acid
sequence of human insulin-like growth factor I and its
structural homology with proinsulin,” Journal of Biological
Chemistry, vol. 253, no. 8, pp. 2769–2776, 1978.
[87] C. A. Benbassat, K. C. Maki, and T. G. Unterman, “Cir-
culating levels of insulin-like growth factor (IGF) binding
protein- 1 and -3 in aging men: relationships to insulin,
glucose, IGF, and dehydroepiandrosterone sulfate levels and
anthropometric measures,” Journal of Clinical Endocrinology
and Metabolism, vol. 82, no. 5, pp. 1484–1491, 1997.
[88] E. Corpas, S. M. Harman, and M. R. Blackman, “Human
growth hormone and human aging,” Endocrine Reviews,v o l .
14, no. 1, pp. 20–39, 1993.
[89] D.Rudman,A.G.Feller,H.S.Nagrajetal.,“Eﬀects ofhuman
growth hormone in men over 60 years old,” New England
Journal of Medicine, vol. 323, no. 1, pp. 1–6, 1990.
[90] S. N. Rajpathak, M. J. Gunter, J. Wylie-Rosett et al., “The role
ofinsulin-likegrowthfactor-Ianditsbindingproteinsinglu-
cose homeostasis and type 2 diabetes,” Diabetes/Metabolism
Research and Reviews, vol. 25, no. 1, pp. 3–12, 2009.
[91] “The Diabetes Prevention Program (DPP): description of
lifestyle intervention,” Diabetes Care, vol. 25, no. 12, pp.
2165–2171, 2002.
[92] N. G. Boule, E. Haddad, G. P. Kenny, G. A. Wells, and R.
J. Sigal, “Eﬀects of exercise on glycemic control and body
massintype2diabetes mellitus:ameta-analysisofcontrolled
clinical trials,” Journal of the American Medical Association,
vol. 286, no. 10, pp. 1218–1227, 2001.
[ 9 3 ]D .R .D e n g e l ,R .E .P r a t l e y ,J .M .H a g b e r g ,E .M .R o g u s ,a n d
A. P. Goldberg, “Distinct eﬀects of aerobic exercise training
and weight loss on glucose homeostasis in obese sedentary
men,” Journal of Applied Physiology, vol. 81, no. 1, pp. 318–
325, 1996.
[94] R. J. Sigal, G. P. Kenny, D. H. Wasserman, C. Castaneda-
Sceppa, and R. D. White, “Physical activity/exercise and
type 2 diabetes: a consensus statement from the American
Diabetes Association,”DiabetesCare,vol.29,no.6,pp. 1433–
1438, 2006.
[95] M. A. Fiatarone, E. F. O’Neill, N. D. Ryan et al., “Exercise
training and nutritional supplementation for physical frailty
in very elderly people,” New England Journal of Medicine,v o l .
330, no. 25, pp. 1769–1775, 1994.
[ 9 6 ]M .K .H o l t e n ,M .Z a c h o ,M .G a s t e r ,C .J u e l ,J .F .P .W o j -
taszewski, and F. Dela, “Strength training increases insulin-
mediated glucose uptake, GLUT4 content, and insulin sig-
naling in skeletal muscle in patients with type 2 diabetes,”
Diabetes, vol. 53, no. 2, pp. 294–305, 2004.
[97] M. Rantakokko, S. Iwarsson, M. Hirvensalo, R. Leinonen, E.
Heikkinen, and T. Rantanen, “Unmet physical activity need
in old age,” Journal of the American Geriatrics Society,vol. 58,
no. 4, pp. 707–712, 2010.
[98] O. Seynnes, M. A. F. Singh, O. Hue, P. Pras, P. Legros,
and P. L. Bernard, “Physiological and functional responses
to low-moderate versus high-intensity progressive resistance
training in frail elders,” Journals of Gerontology A, Biological
Sciences and Medical Sciences, vol. 59, no. 5, pp. 503–509,
2004.
[99] M.A.FiataroneSingh,W.Ding,T.J.Manfredietal.,“Insulin-
like growth factor I in skeletal muscle after weight-lifting
exercise in frail elders,” American Journal of Physiology,v o l .
277, no. 1, part 1, pp. E135–E143, 1999.
[100] N. A. Singh, K. M. Clements, and M. A. Fiatarone, “A
randomizedcontrolled trialofprogressive resistancetraining
in depressed elders,” Journals of Gerontology A, Biological
Sciences and Medical Sciences, vol. 52, no. 1, pp. M27–M35,
1997.
[101] B. F. Hurley, R. A. Redmond, R. E. Pratley, M. S. Treuth, M.
A. Rogers, and A. P. Goldberg, “Eﬀects of strength training
on muscle hypertrophy and muscle cell disruption in elder
men,” International Journal of Sports Medicine, vol. 16, no. 6,
pp. 378–384, 1995.
[102] S. Steib, D. Schoene, and K. Pfeifer, “Dose-response relation-
ship of resistance training in older adults: a meta-analysis,”
Medicine and ScienceinSports andExercise,v o l .4 2 ,n o .5 ,p p .
902–914, 2010.
[103] “Standardsofmedicalcareindiabetes—2006,”DiabetesCare,
vol. 29, supplement 1, pp. S4–S42, 2006.
[104] V. Kumar, A. Selby, D. Rankin et al., “Age-related diﬀerences
in the dose-response relationshipof muscleprotein synthesis
to resistance exercise in young and old men,” Journal of
Physiology, vol. 587, no. 1, pp. 211–217, 2009.
[105] U.S.Department ofHealthandHumanSercices,C.f.D.C.a.P.,
National Center for Chronic Disease Prevention and Health
Promotion,“U.S.Department ofhealthandHumanServices:
Physical Activity and health: A Report of the Surgeon
General,” Atlanta, 1996.
[106] L. E. Black, P. D. Swan, and B. A. Alvar, “Eﬀects of intensity
and volume on insulin sensitivity during acute bouts of
resistance training,” Journal of Strength and Conditioning
Research, vol. 24, no. 4, pp. 1109–1116, 2010.
[107] J. Eriksson, J. Tuominen, T. Valle et al., “Aerobic endurance
exercise or circuit-type resistance training for individualsJournal of Aging Research 11
with impaired glucose tolerance?” Hormone and Metabolic
Research, vol. 30, no. 1, pp. 37–41, 1998.
[108] M. A. Smutok, C. Reece, P. F. Kohhinos et al., “Eﬀects of
exercise training modality on glucose tolerance in men with
abnormal glucose regulation,” International Journal of Sports
Medicine, vol. 15, no. 6, pp. 283–289, 1994.
[109] M. A. Smutok,C. Reece, P. F. Kokkinos et al.,“Aerobic versus
strength training for risk factor intervention in middle- aged
menathigh risk forcoronaryheart disease,”Metabolism,v ol.
42, no. 2, pp. 177–184, 1993.
[110] G. L. Onamb´ el´ e-Pearson, L. Breen, and C. E. Stewart, “Inﬂu-
ence of exercise intensity in older persons with unchanged
habitual nutritional intake: skeletal muscle and endocrine
adaptations,” Age, vol. 32, no. 2, pp. 139–153, 2010.
[111] C. Jimenez, M. Santiago, M. Sitler, G. Boden, and C.
Homko, “Insulin-sensitivity response to a single bout of
resistive exercise in type 1 diabetes mellitus,” Journal of Sport
Rehabilitation, vol. 18, no. 4, pp. 564–571, 2009.
[112] B. B. Yaspelkis, “Resistance training improves insulin signal-
ing and action in skeletal muscle,” Exercise and Sport Sciences
Reviews, vol. 34, no. 1, pp. 42–46, 2006.
[113] A. D. Krisan, D. E. Collins, A. M. Crain et al., “Resistance
training enhances components of the insulin signaling
cascade in normal and high-fat-fed rodent skeletal muscle,”
Journal of Applied Physiology, vol. 96, no. 5, pp. 1691–1700,
2004.
[114] B. B. Yaspelkis III, M. K. Singh, B. Trevino, A. D. Krisan,
and D. E. Collins, “Resistance training increases glucose
uptakeandtransportinratskeletalmuscle,”Acta Physiologica
Scandinavica, vol. 175, no. 4, pp. 315–323, 2002.
[115] C. J. Behre, A. Gummesson, M. Jern˚ as et al., “Dissociation
between adipose tissue expression and serum levels of
adiponectin during and after diet-induced weight loss in
obese subjects with and without the metabolic syndrome,”
Metabolism, vol. 56, no. 8, pp. 1022–1028, 2007.
[116] J.Ibanez,M.Izquierdo, C.Mart´ ınez-Labariet al.,“Resistance
trainingimprovescardiovascularriskfactorsinobesewomen
despite a signiﬁcative decrease in serum adiponectin levels,”
Obesity, vol. 18, no. 3, pp. 535–541, 2010.
[117] E. P. Weiss,S.B. Racette, D. T. Villarealet al.,“Improvements
inglucose tolerance and insulinactioninduced by increasing
energy expenditure or decreasing energy intake: a random-
ized controlled trial,” American Journal of Clinical Nutrition,
vol. 84, no. 5, pp. 1033–1042, 2006.
[118] A. Oberbach, A. T¨ onjes, N. Kl¨ oting et al., “Eﬀect of a 4
week physical training program on plasma concentrations
of inﬂammatory markers in patients with abnormal glucose
tolerance,” European Journal of Endocrinology, vol. 154,no. 4,
pp. 577–585, 2006.
[119] I. G. Fatouros, A. Chatzinikolaou,S. Tournis et al., “Intensity
of resistance exercise determines adipokine and resting
energy expenditure responses in overweight elderly individ-
uals,” Diabetes Care, vol. 32, no. 12, pp. 2161–2167, 2009.
[120] N. Brooks, J. E. Layne, P. L. Gordon, R. Roubenoﬀ,M .
E. Nelson, and C. Castaneda-Sceppa, “Strength training
improves muscle quality and insulin sensitivity in Hispanic
older adults with type 2 diabetes,” International Journal of
Medical Sciences, vol. 4, no. 1, pp. 19–27, 2007.
[121] M. W. Hulver, D. Zheng, C. J. Tanner et al., “Adiponectin is
not altered with exercise training despite enhanced insulin
action,” American Journal of Physiology, vol. 283, no. 4, pp.
E861–E865, 2002.
[122] E. Klimcakova, J. Polak, C. Moro et al., “Dynamic strength
training improves insulin sensitivity without altering plasma
levels and gene expression of adipokines in subcutaneous
adipose tissue in obese men,” Journal of Clinical Endocrinol-
ogy and Metabolism, vol. 91, no. 12, pp. 5107–5112, 2006.
[123] J. S. Greiwe, C. Bo, D. C. Rubin, K. E. Yarasheski, and C. F.
Semenkovich, “Resistance exercise decreases skeletal muscle
tumor necrosis factor α in frail elderly humans,” FASEB
Journal, vol. 15, no. 2, pp. 475–482, 2001.
[124] M. D. Phillips, M. G. Flynn, B. K. McFarlin, L. K. Stew-
art, and K. L. Timmerman, “Resistance training at eight-
repetition maximum reduces the inﬂammatory milieu in
elderly women,” Medicine and Science in Sports and Exercise,
vol. 42, no. 2, pp. 314–325, 2010.
[125] S. E. Borst, D. V. De Hoyos, L. Garzarella et al., “Eﬀects
of resistance training on insulin-like growth factor-I and
IGF binding proteins,” Medicine and Science in Sports and
Exercise, vol. 33, no. 4, pp. 648–653, 2001.
[126] S. E. Borst, K. R. Vincent, D. T. Lowenthal,and R. W. Braith,
“Eﬀects of resistance training on insulin-like growth factor
and its binding proteins in men and women aged 60 to 85,”
Journal of the American Geriatrics Society,v o l .5 0 ,n o .5 ,p p .
884–888, 2002.
[127] S. Bermon, P. Ferrari, P. Bernard, S. Altare, and C. Dolisi,
“Responses of total and free insulin-like growth factor-I and
insulin-like growth factor binding protein-3 after resistance
exercise and training in elderly subjects,” Acta Physiologica
Scandinavica, vol. 165, no. 1, pp. 51–56, 1999.
[128] H. R. Kwon et al., “The eﬀects of resistance training on
muscle and body fat mass and muscle strength in type 2
diabetic women,” Korean Diabetes Journal,v o l .3 4 ,n o .2 ,p p .
101–110, 2010.
[129] M. S. Treuth, G. R. Hunter, T. Kekes-Szabo, R. L. Weinsier,
M. I. Goran, and L. Berland, “Reduction in intra-abdominal
adipose tissue after strength training in older women,”
Journal of Applied Physiology, vol. 78, no. 4, pp. 1425–1431,
1995.
[130] W. J. Chodzko-Zajko et al., “American college of sports
medicine position stand. Exercise and physical activity for
older adults,” Medicine&ScienceinSports&Exercise, vol.41,
no. 7, pp. 1510–1530, 2009.
[131] A. Albright, M. Franz, G. Hornsby, A. Kriska, D. Marrero,
and I. Ullrich, “ACSM position stand on exercise and type 2
diabetes,” MedicineandScienceinSportsandExercise, vol.32,
no. 7, pp. 1345–1360, 2000.
[132] N. Lundebjerg, “Exercise prescription for older adults with
osteoarthritis pain: consensus practice recommendations,”
Journal of the American Geriatrics Society,v o l .4 9 ,n o .6 ,p p .
808–823, 2001.
[133] M. A. Williams, W. L. Haskell, P. A. Ades et al., “Resistance
exercise in individuals with and without cardiovascular
disease: 2007 update: a scientiﬁc statement from the Amer-
ican Heart Association Council on Clinical Cardiology and
Council on Nutrition, Physical Activity, and Metabolism,”
Circulation, vol. 116, no. 5, pp. 572–584, 2007.
[134] M. D. Peterson, A. Sen, and P. M. Gordon, “Inﬂuence of
resistance exercise onleanbody massinagingadults: a meta-
analysis,”Medicine & Science in Sports & Exercise.I np r e s s .
[135] N. A. Burd, A. M. Holwerda, K. C. Selby et al., “Resis-
t a n c ee x e r c i s ev o l u m ea ﬀects myoﬁbrillar protein synthesis
and anabolic signalling molecule phosphorylation in young
men,” Journal of Physiology, vol. 588, no. 16, pp. 3119–3130,
2010.
[136] S. Kodama, M. Shu, K. Saito et al., “Even low-intensity and
low-volume exercise training may improve insulin resistance12 Journal of Aging Research
in the elderly,” Internal Medicine, vol. 46, no. 14, pp. 1071–
1077, 2007.
[137] N. A. Burd, D. W. D. West, A. W. Staples et al., “Low-load
high volume resistance exercise stimulates muscle protein
synthesismorethanhigh-loadlowvolumeresistanceexercise
in young men,” PLoS One, vol. 5, no. 8, p. 10, 2010.
[138] S. M. Phillips and R. A. Winett, “Uncomplicated resistance
training and health-related outcomes: evidence for a public
health mandate,” Current Sports Medicine Reports,v o l .9 ,n o .
4, pp. 208–213, 2010.
[139] Strength Training among adults aged ≥65—United States,
2001, 2001.
[140] M. C. Gannon and F. Q. Nuttall, “Eﬀect of a high-protein,
low-carbohydrate diet on blood glucose control in people
withtype 2diabetes,” Diabetes, vol. 53, no. 9, pp. 2375–2382,
2004.
[141] M. C. Gannon, F. Q. Nuttall, A. Saeed, K. Jordan, and H.
Hoover, “An increase in dietary protein improves the blood
glucose response in persons with type 2 diabetes,” American
JournalofClinical Nutrition,vol.78,no.4,pp.734–741,2003.
[142] W. W. Campbell and H. J. Leidy, “Dietary protein and
resistance training eﬀects on muscle and body composition
inolderpersons,”JournaloftheAmerican CollegeofNutrition,
vol. 26, no. 6, pp. 696S–703S, 2007.